Carregant...
Immunotherapy in colorectal cancer: for the select few or all?
Over the past few years, the role of immunotherapy in colorectal cancer (CRC) has expanded, specifically in subsets of CRC with microsatellite instability (MSI) for which newer agents, such as programmed death-1 (PD-1) inhibitors, are efficacious. While other immunotherapeutic agents are more immatu...
Guardat en:
| Publicat a: | J Gastrointest Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AME Publishing Company
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5848030/ https://ncbi.nlm.nih.gov/pubmed/29564183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.06.10 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|